News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eli Lilly and Company (LLY) Gets A Huge Blow As FDA OKs Cymbalta Generics


12/12/2013 7:28:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Food and Drug Administration on Wednesday approved generic versions of Eli Lilly and Co's antidepressant Cymbalta, the U.S. drugmaker's biggest-selling product. The drug, which has annual sales of about $5 billion, was expected to lose patent protection this month. The FDA said it approved cheaper versions of the drug, known chemically as duloxetine, in a variety of strengths for sale by several generic drugmakers, including Teva Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy's Laboratories Ltd, Lupin Ltd, Sun Pharmaceutical Industries and Torrent Pharmaceuticals Ltd.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release
Read at Washington Post


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES